Who Owns PMVP?

PMV Pharmaceuticals, Inc. — Institutional Ownership & 13F Holdings

$1.44

-0.01 (-0.35%)

Market Cap

$76.8M

Shares Outstanding

53,329,392

Institutional Holders

55

Total Inst. Value

$37.1M

% of Float Held

85.0%

QoQ Holder Change

-33

Institutional data as of Q1 2025

New Positions

2

Closed Positions

16

Increased

8

Decreased

33

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1ORBIMED ADVISORS LLC$7.1M6,475,291
2BML Capital Management, LLC$4.1M3,747,612
3Sio Capital Management, LLC$4.1M3,735,396
4PFM Health Sciences, LP$3.6M3,301,942
5Euclidean Capital LLC$2.9M2,627,643
6ALKEON CAPITAL MANAGEMENT LLC$2.6M2,342,373
7VANGUARD GROUP INC$2.4M2,175,061
8ACADIAN ASSET MANAGEMENT LLC$2.2M2,047,177
9BlackRock, Inc.$1.2M1,144,396
10D. E. Shaw & Co., Inc.$1.0M949,726

Biggest Buyers & Sellers This Quarter

Related Stocks

Frequently Asked Questions

How many institutional investors hold PMVP?

As of Q1 2025, 55 institutional investors report holding PMVP (PMV Pharmaceuticals, Inc.) in their 13F filings.

What percentage of PMV Pharmaceuticals, Inc. is owned by institutions?

Institutional investors hold approximately 85.0% of PMV Pharmaceuticals, Inc.'s float as reported in SEC 13F filings.

Which hedge fund owns the most PMVP?

The largest institutional holder of PMVP is ORBIMED ADVISORS LLC with $7.1M in shares.

Are institutions buying or selling PMVP?

This quarter, 2 institutions opened new positions in PMVP and 16 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.